Swedencare Ab Stock Fundamentals
| SWDCF Stock | USD 3.87 0.27 7.50% |
Fundamental analysis of Swedencare allows traders to better anticipate movements in Swedencare's stock price by examining its financial health and performance throughout various phases of its business cycle.
Swedencare |
Swedencare AB OTC Stock Return On Equity Analysis
Swedencare's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Swedencare Return On Equity | 0.0284 |
Most of Swedencare's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Swedencare AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Swedencare AB has a Return On Equity of 0.0284. This is 100.12% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 109.16% lower than that of the firm.
Swedencare AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Swedencare's current stock value. Our valuation model uses many indicators to compare Swedencare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Swedencare competition to find correlations between indicators driving Swedencare's intrinsic value. More Info.Swedencare AB is rated fifth in return on equity category among its peers. It is currently regarded as top stock in return on asset category among its peers reporting about 0.29 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Swedencare AB is roughly 3.51 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Swedencare's earnings, one of the primary drivers of an investment's value.Swedencare Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Swedencare's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Swedencare could also be used in its relative valuation, which is a method of valuing Swedencare by comparing valuation metrics of similar companies.Swedencare is currently under evaluation in return on equity category among its peers.
Swedencare Fundamentals
| Return On Equity | 0.0284 | |||
| Return On Asset | 0.0081 | |||
| Profit Margin | 0.09 % | |||
| Current Valuation | 793.04 M | |||
| Shares Outstanding | 158.73 M | |||
| Shares Owned By Insiders | 63.52 % | |||
| Shares Owned By Institutions | 24.78 % | |||
| Price To Earning | 55.56 X | |||
| Price To Book | 0.71 X | |||
| Price To Sales | 3.57 X | |||
| Revenue | 770.44 M | |||
| Gross Profit | 388.64 M | |||
| EBITDA | 137.5 M | |||
| Net Income | 54.62 M | |||
| Total Debt | 616.97 M | |||
| Debt To Equity | 0.22 % | |||
| Current Ratio | 2.14 X | |||
| Cash Flow From Operations | 125.85 M | |||
| Earnings Per Share | 0.12 X | |||
| Number Of Employees | 506 | |||
| Beta | 1.11 | |||
| Market Capitalization | 522.57 M | |||
| Total Asset | 3.47 B | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 3.47 B |
About Swedencare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Swedencare AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Swedencare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Swedencare AB based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Swedencare AB , together with its subsidiaries, develops, manufactures, markets, and sells pet healthcare products. Swedencare AB was incorporated in 1993 and is headquartered in Malm, Sweden. Swedencare is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Swedencare OTC Stock
Swedencare financial ratios help investors to determine whether Swedencare OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Swedencare with respect to the benefits of owning Swedencare security.